Modulation of tau pathology in tau transgenic models

Biochemical Society Transactions

Volumn 38, Issue 4, 2010, Pages 996-1000

  Brion, Jean Pierre ^a   Ando, Kunie ^a   Heraud, Céline ^a   Leroy, Karelle ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alzheimer's disease; Amyloid; Neurofibrillary tangle (NFT); Tau; Tauopathy; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CROSS BREEDING; GENE OVEREXPRESSION; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REVIEW; TAUOPATHY; TRANSGENIC ANIMAL;

AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL DEATH; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEURONS; PROTEIN MULTIMERIZATION; TAU PROTEINS; TAUOPATHIES;

MUS; MUS MUSCULUS;

EID: 77955953761     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380996     Document Type: Review

References (48)

1. Goedert, M. and Spillantini, M.G. (2006) A century of Alzheimer's disease. Science 314, 777-781
2. Braak, H. and Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239-259
3. Thal, D.R., Rub, U., Orantes, M. and Braak, H. (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800
4. Brion, J.-P. (2006) Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease. J. Alzheimer's Dis. 9, 177-185
5. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356
6. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. and Hyman, B.T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639
7. Ballatore, C., Lee, V.M. Y. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672
8. Spires-Jones, T.L., Stoothoff, W.H., de Calignon, A., Jones, P.B. and Hyman, B.T. (2009) Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 32, 150-159
9. Gotz, J. and Ittner, L.M. (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532-544
10. Bondareff, W., Mountjoy, C.Q., Roth, M. and Hauser, D.L. (1989) Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol. Aging 10, 709-715
11. Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E. and Hyman, B.T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24
12. Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E. and Brayne, C. (2009) Age, neuropathology, and dementia. N. Engl. J. Med. 360, 2302-2309
13. Schindowski, K., Bretteville, A., Leroy, K., Begard, S., Brion, J.-P., Hamdane, M. and Buée, L. (2006) Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol. 169, 599-616
14. Gotz, J., Deters, N., Doldissen, A., Bokhari, L., Ke, Y.Z., Wiesner, A., Schonrock, N. and Ittner, L.M. (2007) A decade of tau transgenic animal models and beyond. Brain Pathol. 17, 91-103
15. Eckermann, K., Mocanu, M.M., Khlistunova, I., Biernat, J., Nissen, A., Hofmann, A., Schonig, K., Bujard, H., Haemisch, A., Mandelkow, E. et al. (2007) The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem. 282, 31755-31765
16. Spires, T.L., Orne, J.D., SantaCruz, K., Pitstick, R., Carlson, G.A., Ashe, K.H. and Hyman, B.T. (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168, 1598-1607
17. SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E. et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481
18. Spires-Jones, T.L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.Y., Osetek, J.D., Jones, P.B., Bacskai, B.J., Feany, M.B. et al. (2008) In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci. 28, 862-867
19. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L. and Brion, J.-P. (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am. J. Pathol. 171, 976-992
20. Leroy, K., Ando, K., Heraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.M., Buée, L., De Decker, R. and Brion, J.-P. (2010) Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. J. Alzheimer's Dis. 19, 705-719
21. Ando, K., Leroy, K., Heraud, C., Kabova, A., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R. and Brion, J.-P. (2010) Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochem. Soc. Trans. 38, 1001-1005
22. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714
23. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519
24. Iqbal, K., Liu, F., Gong, C.X., Alonso, A.D. and Grundke-Iqbal, I. (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 118, 53-69
25. Fath, T., Eidenmüller, J. and Brandt, R. (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22, 9733-9741
26. Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D. et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650-3662
27. Clavaguera, F., Bolmont, T., Crowther, R.A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A.K., Beibel, M., Staufenbiel, M. et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913
28. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q. and Lee, V.M.Y. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351
29. Duyckaerts, C. (2004) Looting for the link between plaques and tangles. Neurobiol. Aging 25, 735-739
30. Small, S.A. and Duff, K. (2008) Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60, 534-542
31. Boutajangout, A., Leroy, K., Touchet, N., Authelet, M., Blanchard, V., Tremp, G., Pradier, L. and Brion, J.-P. (2002) Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Neurosci. Lett. 318, 29-33
32. Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G., Pradier, L. and Brion, J.-P. (2004) Cytoskeletal abnormalities in mice transgenic for human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol. Dis. 15, 47-60
33. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D. et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491
34. Perez, M., Ribe, E., Rubio, A., Lim, F., Moran, M.A., Ramos, P.G., Ferrer, I., Isla, M.T. and Avila, J. (2005) Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130, 339-347
35. Bolmont, T., Clavaguera, F., Meyer-Luehmann, M., Herzig, M.C., Radde, R., Staufenbiel, M., Lewis, J., Hutton, M., Tolnay, M. and Jucker, M. (2007) Induction of tau pathology by intracerebral infusion of amyloid-β- containing brain extract and by amyloid-β deposition in APP x tau transgenic mice. Am. J. Pathol. 171, 2012-2020
36. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H. and Van Leuven, F. (2008) Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 172, 786-798
37. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421
38. Oddo, S., Billings, L., Kesslak, J.-P., Cribbs, D.H. and LaFerla, F.M. (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332
39. Götz, J., Chen, F., Van Dorpe, J. and Nitsch, R.M. (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293, 1491-1495
40. Ribe, E.M., Perez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S., Sanchez, B., Nieto, M. et al. (2005) Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis. 20, 814-822
41. Oddo, S., Caccamo, A., Cheng, D., Jouleh, B., Torp, R. and LaFerla, F.M. (2007) Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice. J. Neurochem. 102, 1053-1063
42. Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L. et al. (2006) Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140
43. Ashe, K.H. (2005) Mechanisms of memory loss in Aβ and tau mouse models. Biochem. Soc. Trans. 33, 591-594
44. Tseng, B.P., Green, K.N., Chan, J.L., Blurton-Jones, M. and LaFerla, F.M. (2008) Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 29, 1607-1618
45. Rohn, T.T., Vyas, V., Hernandez-Estrada, T., Nichol, K.E., Christie, L.A. and Head, E. (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J. Neurosci. 28, 3051-3059
46. Rapoport, M., Dawson, H.N., Binder, L.I., Vitek, M.P. and Ferreira, A. (2002) Tau is essential to β-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 6364-6369
47. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F.R., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754
48. Tucker, K.L., Meyer, M. and Barde, Y.A. (2001) Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29-37